Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

Real-life ‘gold-devouring beast’: Chinese girl, 5, hospitalised after swallowing gold bar

A five-year-old girl in northern China accidentally swallowed a 50-gram gold bar, sparking viral jokes online that she took the mainland nickname for children – “gold-devouring beasts” – far too literally. The Beijing Children’s Hospital, affiliated with Capital Medicine University, reported the case that was treated on August 16. The girl was brought to the hospital after accidentally swallowing…

Real-life ‘gold-devouring beast’: Chinese girl, 5, hospitalised after swallowing gold bar

A five-year-old girl in northern China accidentally ingested a 50-gram gold bar, leading to her hospitalization on August 16. The incident, treated at Beijing Children’s Hospital, raised concerns about the phrase "gold-devouring beasts," a popular nickname for children in China. The gold bar, measuring 4cm in length and weighing 50 grams, became lodged in the girl's stomach after she swallowed it while playing at home.

X-rays revealed the object's presence, and doctors performed an intraoperative endoscopy to remove it carefully due to the narrow operating conditions. The gold bar's hard and dense nature, along with its smooth surface, posed a risk of scratching the stomach lining and causing serious complications. The girl's condition improved after successful removal, and she recovered well.

The case highlights the dangers of children ingesting foreign objects and emphasizes the importance of responsible parenting in monitoring and safeguarding children's environments.

Written by urgent.news from South China Morning Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at scmp.com →

More in Health & Medicine

Chong Kun Dang Signs KIO-301 Deal

Chong Kun Dang has joined hands with a US pharmaceutical company to treat a rare inherited retinal disease estimated to affect more than 10,000 patients in South Korea.Chong Kun Dang signed a…

  • Chong Kun Dang partners with Kiora Pharmaceuticals for KIO-301 development.
  • KIO-301 targets retinitis pigmentosa, affecting over 10,000 South Koreans.
  • Collaboration aims to expedite domestic clinical and approval processes.

More from Friday 21 August →